Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier

Regan Ashby

Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier

Research output: Patent

Abstract

Disclosed are compositions comprising levodopa and an antioxidant for inhibiting the development or progression of visual disorders inclusive of visual disorders associated with diabetic retinopathy or Parkinson's disease, and myopia.

Original language	English
Patent number	WO2017177262A1
IPC	A61K 31/198,A61K 31/375,A61P 21/02,A61P 27/10
Priority date	11/04/16
Filing date	10/04/17
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://patents.google.com/patent/WO2017177262A1/en

Cite this

@misc{d7f2e8454ed5456aa6dd8b08744dcfe5,

title = "Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier",

abstract = "Disclosed are compositions comprising levodopa and an antioxidant for inhibiting the development or progression of visual disorders inclusive of visual disorders associated with diabetic retinopathy or Parkinson's disease, and myopia.",

author = "Regan Ashby",

year = "2017",

language = "English",

publisher = "University of Canberra",

type = "Patent",

note = "WO2017177262A1; A61K 31/198,A61K 31/375,A61P 21/02,A61P 27/10",

}

TY - PAT

T1 - Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier

AU - Ashby, Regan

PY - 2017

Y1 - 2017

N2 - Disclosed are compositions comprising levodopa and an antioxidant for inhibiting the development or progression of visual disorders inclusive of visual disorders associated with diabetic retinopathy or Parkinson's disease, and myopia.

AB - Disclosed are compositions comprising levodopa and an antioxidant for inhibiting the development or progression of visual disorders inclusive of visual disorders associated with diabetic retinopathy or Parkinson's disease, and myopia.

M3 - Patent

M1 - WO2017177262A1

Y2 - 2017/04/10

PB - University of Canberra

ER -

Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this